Abstract
Background: Chronic treatment with sodium valproate (VPA) can lead to elevation of specific oxidative metabolites that associated with the drug’s toxicity. Results: Valproate exposure leads to an increase in reactive oxygen species (ROS). The levels of lipid peroxidation (malondialdehyde), and lipid profile variables (cholesterol, phospholipids, triglycerides and free fatty acids) were significantly increased (p<0.001) in orally administrated rats with sodium valproate at 400 mg/kg body weight/day. Also the deflection in the activities of catalase (CAT), lactate dehydrogenase (LDH) and Na,K-ATPase was registered where CAT, LDH and Na-K, ATPase activities were decreased (p<0.001) in rats under VPA treatment compared to the controls. These changes were more pronounced in valproate 60 days treated group than in valproate 30 days treated group. Oral administration of l-carnitine (L-CAR) at 300 mg/kg b. w. /day showed alleviation in all metabolic and physiologic changes in rats treated with sodium valproate. L-CAR supplementation might be recommended for human especially for epileptic persons subjected for long term to sodium valproate treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
